(2S)-2-[(7-fluoroquinazolin-4-yl)amino]-4-[2-methoxyethyl-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]butanoic acid

ID: ALA5200205

Chembl Id: CHEMBL5200205

PubChem CID: 139464179

Max Phase: Preclinical

Molecular Formula: C27H35FN6O3

Molecular Weight: 510.61

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCN(CCCCc1ccc2c(n1)NCCC2)CC[C@H](Nc1ncnc2cc(F)ccc12)C(=O)O

Standard InChI:  InChI=1S/C27H35FN6O3/c1-37-16-15-34(13-3-2-6-21-9-7-19-5-4-12-29-25(19)32-21)14-11-23(27(35)36)33-26-22-10-8-20(28)17-24(22)30-18-31-26/h7-10,17-18,23H,2-6,11-16H2,1H3,(H,29,32)(H,35,36)(H,30,31,33)/t23-/m0/s1

Standard InChI Key:  SQXIAJNIFTZJMD-QHCPKHFHSA-N

Alternative Forms

  1. Parent:

    ALA5200205

    ---

Associated Targets(Human)

ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 510.61Molecular Weight (Monoisotopic): 510.2755AlogP: 3.75#Rotatable Bonds: 14
Polar Surface Area: 112.50Molecular Species: ZWITTERIONHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.75CX Basic pKa: 9.70CX LogP: 0.67CX LogD: 0.39
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.28Np Likeness Score: -0.91

References

1. Kargbo RB..  (2022)  SARS-CoV-2: Novel Therapeutic Approaches for Diagnosis and Treatment.,  13  (7.0): [PMID:35928857] [10.1021/acsmedchemlett.2c00231]

Source